Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 3

Status

Active not recruiting 3Recruiting 2Not yet recruiting 1

Sponsor Class

NIH 3OTHER 2NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Other solid neoplasm 6

Conditions

Breast Neoplasms 311Carcinoma, Non-Small-Cell Lung 276Neoplasms 255Prostatic Neoplasms 216Colorectal Neoplasms 196Lung Neoplasms 153Multiple Myeloma 148Neoplasm Metastasis 135Ovarian Neoplasms 126Leukemia, Myeloid, Acute 123Pancreatic Neoplasms 116Melanoma 102Squamous Cell Carcinoma of Head and Neck 97Recurrence 85Endometrial Neoplasms 82Carcinoma, Renal Cell 80Glioblastoma 78Lymphoma, Non-Hodgkin 77Stomach Neoplasms 73Precursor Cell Lymphoblastic Leukemia-Lymphoma 72Lymphoma 72Carcinoma, Hepatocellular 72Glioma 65Brain Neoplasms 65Uterine Cervical Neoplasms 63Sarcoma 63Head and Neck Neoplasms 63Triple Negative Breast Neoplasms 59Leukemia, Lymphocytic, Chronic, B-Cell 58Urinary Bladder Neoplasms 55

Interventions

Specimen Handling 3Biopsy 3X-Rays 2Standard of Care 2Practice Guidelines as Topic 2Interviews as Topic 2trastuzumab biosimilar HLX02 1pertuzumab 1erdafitinib 1copanlisib 1Trastuzumab 1Palliative Care 1PF-05280014 1Ontruzant 1Ogivri 1Methods 1Magnetic Resonance Spectroscopy 1Health Promotion 1Educational Status 1Early Intervention, Educational 1CT-P6 12C4 antibody 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Malignant Solid Neoplasm × 30 days × Clear all
NCT06136897 2026-05-29

Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J)

National Cancer Institute (NCI)

Phase 2 Active not recruiting
35 enrolled 10 charts
Other solid neoplasm

Malignant Solid Neoplasm

NCT06351371 2026-05-28

Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Mutations or Fusions (MATCH - Subprotocol K2)

National Cancer Institute (NCI)

Phase 2 Active not recruiting
35 enrolled 10 charts
Other solid neoplasm

Malignant Solid Neoplasm

NCT06360588 2026-05-28

Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G)

National Cancer Institute (NCI)

Phase 2 Active not recruiting
22 enrolled 9 charts
Other solid neoplasm

Malignant Solid Neoplasm

NCT06541158 2026-05-28

TRACT

Emory University

Phase NA Recruiting
76 enrolled
Other solid neoplasm

Malignant Solid Neoplasm

NCT06771739 2026-05-22

A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial

Fred Hutchinson Cancer Center

Phase NA Not yet recruiting
20 enrolled
Other solid neoplasm

Malignant Solid Neoplasm

NCT06295367 2026-05-15

Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)

Eastern Cooperative Oncology Group

Phase NA Recruiting
760 enrolled
Other solid neoplasm

Malignant Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡